These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33795573)

  • 41. Efficacy, Safety, and Tolerability of 4% 5-Fluorouracil Cream in a Novel Patented Aqueous Cream Containing Peanut Oil Once Daily Compared With 5% 5-Fluorouracil Cream Twice Daily: Meeting the Challenge in the Treatment of Actinic Keratosis.
    Dohil MA
    J Drugs Dermatol; 2016 Oct; 15(10):1218-1224. PubMed ID: 27741339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.
    Elmets CA; Viner JL; Pentland AP; Cantrell W; Lin HY; Bailey H; Kang S; Linden KG; Heffernan M; Duvic M; Richmond E; Elewski BE; Umar A; Bell W; Gordon GB
    J Natl Cancer Inst; 2010 Dec; 102(24):1835-44. PubMed ID: 21115882
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibrohistiocytic tumors in a lung transplant patient taking oral capecitabine for nonmelanoma skin cancer chemoprevention.
    Konda S; Patel VA; O'Bryan KW; Ratner D
    Dermatol Surg; 2014 Jul; 40(7):807-10. PubMed ID: 24927001
    [No Abstract]   [Full Text] [Related]  

  • 44. Predictors of Basal Cell Carcinoma and Implications for Follow-Up in High-Risk Patients in the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial.
    Beatson M; Misitzis A; Landow S; Yoon J; Higgins HW; Phibbs C; Weinstock MA
    J Cutan Med Surg; 2021; 25(1):102-103. PubMed ID: 32880186
    [No Abstract]   [Full Text] [Related]  

  • 45. Imiquimod induces sustained remission of actinic damage: a case report spanning one decade of observation.
    Knackstedt TJ; Quitadamo M
    Cutis; 2015 Feb; 95(2):E20-3. PubMed ID: 25750973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluorouracil and other predictors of morpheaform basal cell carcinoma among high-risk patients: the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
    Xiong MY; Korgavkar K; Digiovanna JJ; Weinstock MA;
    JAMA Dermatol; 2014 Mar; 150(3):332-4. PubMed ID: 24258386
    [No Abstract]   [Full Text] [Related]  

  • 48. Short incubation fractional CO
    Vrani F; Sotiriou E; Lazaridou E; Vakirlis E; Sideris N; Kirmanidou E; Apalla Z; Lallas A; Ioannides D
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):79-83. PubMed ID: 29869444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemoprevention, risk reduction, therapeutic prevention, or preventive therapy?
    Meyskens FL; McLaren CE
    J Natl Cancer Inst; 2010 Dec; 102(24):1815-7. PubMed ID: 21115881
    [No Abstract]   [Full Text] [Related]  

  • 50. Cicatricial Ectropion With Topical 5% Fluorouracil Cream.
    Tsui M; Tajirian A
    Dermatol Surg; 2016 Aug; 42(8):1005-6. PubMed ID: 27191780
    [No Abstract]   [Full Text] [Related]  

  • 51. Measuring the severity of topical 5-fluorouracil toxicity.
    Korgavkar K; Firoz EF; Xiong M; Lew R; Marcolivio K; Burnside N; Dyer R; Weinstock MA;
    J Cutan Med Surg; 2014; 18(4):229-35. PubMed ID: 25008439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of reflectance confocal microscopy to evaluate 5-fluorouracil 0.5%/salicylic acid 10% in the field-directed treatment of subclinical lesions of actinic keratosis: subanalysis of a Phase III, randomized, double-blind, vehicle-controlled trial.
    Ulrich M; Reinhold U; Falqués M; Rodriguez Azeredo R; Stockfleth E
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):390-396. PubMed ID: 28960520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nicotinamide: New Indications in Dermatology.
    Escudero-Góngora MM; Fernández-Peñas P
    Actas Dermosifiliogr; 2016 Nov; 107(9):777-778. PubMed ID: 27377936
    [No Abstract]   [Full Text] [Related]  

  • 54. In vivo reflectance confocal microscopy characterization of field-directed 5-fluorouracil 0.5%/salicylic acid 10% in actinic keratosis.
    Ulrich M; Alarcon I; Malvehy J; Puig S
    Dermatology; 2015; 230(3):193-8. PubMed ID: 25721522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topical 5-fluorouracil to treat multiple or unresectable facial squamous cell carcinomas in xeroderma pigmentosum.
    Hamouda B; Jamila Z; Najet R; Slim T; Rafiaa N; Noureddine B; Ahmed EM; Mohamed F; Ridha KM; Abderrahman L
    J Am Acad Dermatol; 2001 Jun; 44(6):1054. PubMed ID: 11369927
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial.
    Jorizzo J; Weiss J; Furst K; VandePol C; Levy SF
    Arch Dermatol; 2004 Jul; 140(7):813-6. PubMed ID: 15262691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo Confocal Laser Microscopy for monitoring of actinic keratosis treatment: a comparison with histopathologic assessment after treatment with topical 5% 5-fluorouracil.
    Ishioka P; Maia M; Rodrigues SB; Lellis RF; Hirata SH
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1155-1163. PubMed ID: 29178474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
    Chen AC; Martin AJ; Choy B; Fernández-Peñas P; Dalziell RA; McKenzie CA; Scolyer RA; Dhillon HM; Vardy JL; Kricker A; St George G; Chinniah N; Halliday GM; Damian DL
    N Engl J Med; 2015 Oct; 373(17):1618-26. PubMed ID: 26488693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders.
    Moore AY
    J Dermatolog Treat; 2009; 20(6):328-35. PubMed ID: 19954388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A real-world, community-based cohort study comparing the effectiveness of topical fluorouracil versus topical imiquimod for the treatment of actinic keratosis.
    Neugebauer R; Levandoski KA; Zhu Z; Sokil M; Chren MM; Friedman GD; Asgari MM
    J Am Acad Dermatol; 2018 Apr; 78(4):710-716. PubMed ID: 29277731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.